Bisoprolol fumarate and Creon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bisoprolol fumarate and Creon. Common interactions include osteonecrosis among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people who take Bisoprolol fumarate and Creon have. It is created by eHealthMe based on reports of 65 people who take Bisoprolol fumarate and Creon from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

65 people who take Bisoprolol fumarate and Creon together, and have interactions are studied.

What is Bisoprolol fumarate?

Bisoprolol fumarate has active ingredients of bisoprolol fumarate. It is often used in high blood pressure. eHealthMe is studying from 32,657 Bisoprolol fumarate users for its effectiveness, alternative drugs and more.

What is Creon?

Creon has active ingredients of pancrelipase (amylase;lipase;protease). It is often used in pancreatitis. eHealthMe is studying from 23,954 Creon users for its effectiveness, alternative drugs and more.

Number of Bisoprolol fumarate and Creon reports submitted per year:

Common Bisoprolol Fumarate and Creon drug interactions by gender *:

female:

Osteonecrosis
Overdose
Pain in extremity
Pancreatic carcinoma recurrent
Pancreatitis acute
Pneumonia
Psychomotor hyperactivity
Pulmonary embolism
Rash macular
Respiratory failure

male:

Chronic kidney disease
Renal failure
Anuria
Confusional state
Dermatitis bullous
Diabetes mellitus
Eczema
Extravasation blood
General physical health deterioration
Hyperkeratosis

Common Bisoprolol Fumarate and Creon drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Neck pain
Osteonecrosis
Pulmonary function test decreased
Tremor
Weight decreased
Weight increased
Aphagia
Apnoea
Blepharospasm
Dysphagia

40-49:

Abscess
Nausea
Small intestinal obstruction
Vomiting
Wound complication
Anuria
General physical health deterioration
Pancreatic carcinoma
Renal failure acute
Abdominal adhesions

50-59:

Hypertriglyceridaemia
Abdominal pain
Blood creatine phosphokinase increased
Death
Haemoglobin decreased
Injection site pain

60+:

Cold sweat
Dizziness postural
Hyperkeratosis
Movement disorder
Sopor
Abnormal loss of weight
Aggression
Agranulocytosis
Alanine aminotransferase increased
Ascites

Common conditions people have *:

Pain: 11 people, 16.92%
High Blood Cholesterol: 10 people, 15.38%
Infection: 9 people, 13.85%
Diabetes: 9 people, 13.85%
Depression: 8 people, 12.31%
Type 2 Diabetes: 8 people, 12.31%
Headache (pain in head): 7 people, 10.77%
Constipation: 7 people, 10.77%
Stress And Anxiety: 7 people, 10.77%
Restless Leg Syndrome (a powerful urge to move your legs): 7 people, 10.77%

* Approximation only. Some reports may have incomplete information.

Do you take Bisoprolol fumarate and Creon?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.